Devyser Diagnostics AB (publ) (STO: DVYSR)

Devyser Diagnostics AB Statistics

Total Valuation

Devyser Diagnostics AB has a market cap or net worth of SEK 2.13 billion. The enterprise value is 2.02 billion.

Market Cap	2.13B
Enterprise Value	2.02B

Important Dates

The last earnings date was Wednesday, October 30, 2024.

Earnings Date	Oct 30, 2024
Ex-Dividend Date	n/a

Share Statistics

Devyser Diagnostics AB has 16.51 million shares outstanding. The number of shares has increased by 1.40% in one year.

Current Share Class	n/a
Shares Outstanding	16.51M
Shares Change (YoY)	+1.40%
Shares Change (QoQ)	+1.12%
Owned by Insiders (%)	43.07%
Owned by Institutions (%)	40.47%
Float	9.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.64
PB Ratio	6.09
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.29
EV / Sales	10.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.68

Financial Position

The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.18.

Current Ratio	4.21
Quick Ratio	3.59
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.72
Interest Coverage	-28.27

Financial Efficiency

Return on equity (ROE) is -19.11% and return on invested capital (ROIC) is -10.41%.

Return on Equity (ROE)	-19.11%
Return on Assets (ROA)	-9.32%
Return on Capital (ROIC)	-10.41%
Revenue Per Employee	1.66M
Profits Per Employee	-600,000
Employee Count	118
Asset Turnover	0.40
Inventory Turnover	1.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +98.46% in the last 52 weeks. The beta is 0.76, so Devyser Diagnostics AB's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+98.46%
50-Day Moving Average	130.40
200-Day Moving Average	110.44
Relative Strength Index (RSI)	44.64
Average Volume (20 Days)	42,671

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Devyser Diagnostics AB had revenue of SEK 198.10 million and -71.40 million in losses. Loss per share was -4.37.

Revenue	198.10M
Gross Profit	158.50M
Operating Income	-73.50M
Pretax Income	-73.10M
Net Income	-71.40M
EBITDA	-59.90M
EBIT	-73.50M
Loss Per Share	-4.37

Balance Sheet

The company has 171.40 million in cash and 61.20 million in debt, giving a net cash position of 110.20 million or 6.67 per share.

Cash & Cash Equivalents	171.40M
Total Debt	61.20M
Net Cash	110.20M
Net Cash Per Share	6.67
Equity (Book Value)	349.00M
Book Value Per Share	21.17
Working Capital	197.40M

Cash Flow

In the last 12 months, operating cash flow was -59.10 million and capital expenditures -26.20 million, giving a free cash flow of -85.30 million.

Operating Cash Flow	-59.10M
Capital Expenditures	-26.20M
Free Cash Flow	-85.30M
FCF Per Share	-5.17

Margins

Gross margin is 80.01%, with operating and profit margins of -37.10% and -36.04%.

Gross Margin	80.01%
Operating Margin	-37.10%
Pretax Margin	-36.90%
Profit Margin	-36.04%
EBITDA Margin	-30.24%
EBIT Margin	-37.10%
FCF Margin	-43.06%

Dividends & Yields

Devyser Diagnostics AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.40%
Shareholder Yield	-1.40%
Earnings Yield	-3.39%
FCF Yield	-4.01%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Devyser Diagnostics AB has an Altman Z-Score of 7.91.

Altman Z-Score	7.91
Piotroski F-Score	n/a